Gram Research analysis of a 10-year study of 870 people with Barrett’s esophagus found that smoking and age are the strongest predictors of disease progression, while genetic risk scores provide almost no additional predictive value. Smokers had 4.31 times higher odds of progression, and each additional year of age increased progression risk by 6 percent. Lifestyle factors, particularly smoking cessation and reflux management, should be the focus of risk reduction strategies rather than genetic testing.
A major 10-year study of 870 people with Barrett’s esophagus, a condition that can lead to esophageal cancer, found that lifestyle choices and age are far better predictors of disease progression than genetic tests. Researchers discovered that smoking and getting older significantly increased the risk of developing advanced disease, while genetic risk scores provided almost no additional insight. This finding suggests that doctors should focus on helping patients quit smoking and manage reflux symptoms rather than relying on expensive genetic testing to predict who will develop cancer.
Key Statistics
A 10-year cohort study of 870 people with Barrett’s esophagus found that smokers had 4.31 times higher odds of disease progression compared to non-smokers, making smoking the strongest modifiable risk factor identified.
According to research reviewed by Gram, polygenic risk scores analyzing 41 genetic variants added no independent predictive value to lifestyle factors in predicting Barrett’s esophagus progression in 739 genotyped participants.
In the BarrettNET cohort study, each additional year of age increased the odds of advanced disease at diagnosis by 3 percent, and men were 1.92 times more likely than women to have advanced disease.
A 2026 analysis of 870 Barrett’s esophagus patients found that the predictive model using only lifestyle and demographic factors achieved 82.5 percent accuracy in predicting disease outcomes, with genetic information failing to improve this accuracy.
The Quick Take
- What they studied: Whether lifestyle factors, age, sex, and genetic risk scores could predict which people with Barrett’s esophagus would develop advanced disease or cancer
- Who participated: 870 people with Barrett’s esophagus (a precancerous condition of the food tube) followed for up to 10 years across multiple medical centers. The group included 598 with early-stage disease, 116 with dysplasia (abnormal cells), and 156 with cancer
- Key finding: Smoking increased progression risk by more than 4 times, and older age was consistently associated with worse outcomes. Genetic risk scores, despite testing 41 different genetic variants, did not help predict who would get worse
- What it means for you: If you have Barrett’s esophagus, quitting smoking and managing acid reflux are more important than genetic testing for predicting your disease risk. Talk to your doctor about these modifiable factors rather than focusing on genetic tests
The Research Details
This was a prospective cohort study, meaning researchers followed the same group of people over time and collected information about their habits and health outcomes. Participants completed detailed questionnaires about smoking, alcohol use, exercise, diet, weight, and reflux symptoms. Researchers also measured diet quality using a validated scoring system. The study tracked who developed advanced disease or cancer over the 10-year period.
For a subset of 739 participants, researchers also analyzed genetic information using polygenic risk scores, which combine information from 41 different genetic variants associated with cancer risk. This allowed them to compare whether genetic information added anything beyond what lifestyle factors already predicted.
Statisticians used advanced statistical methods to identify which factors independently predicted advanced disease at diagnosis and which predicted progression during follow-up. They calculated odds ratios, which show how much a factor increases or decreases risk compared to people without that factor.
Understanding which factors actually predict disease progression is crucial for doctors deciding how to monitor and treat patients. If genetic tests don’t help, resources are better spent on modifiable factors like smoking cessation. This study’s long follow-up period and large sample size make it one of the most reliable sources of evidence for Barrett’s esophagus risk prediction
This study is relatively strong because it followed a large group of people over 10 years, used standardized questionnaires to collect consistent information, and included multiple medical centers. However, only 21 people progressed to cancer during follow-up, which is a small number for making predictions. The genetic analysis was limited to 739 of the 870 participants. Results may not apply equally to all ethnic groups since genetic studies often underrepresent certain populations
What the Results Show
Among the 870 participants, older age, male sex, and smoking were the strongest predictors of having advanced disease at the time of diagnosis. Specifically, each additional year of age increased the odds of advanced disease by 3 percent. Men were nearly twice as likely as women to have advanced disease. Smokers had 64 percent higher odds of advanced disease compared to non-smokers.
When researchers looked at the 21 people who actually progressed to cancer during the study, the pattern was similar but even stronger. Older age and smoking were both associated with progression, while having reflux symptoms was actually associated with lower progression risk, possibly because people with noticeable symptoms get monitored more closely.
The most striking finding was that dietary factors and polygenic risk scores showed no independent association with either outcome. Even when researchers added genetic information to their prediction models, it did not improve their ability to predict who would develop advanced disease or progression. The model’s predictive accuracy remained at an area under the curve of 0.825, meaning it correctly predicted outcomes about 82.5 percent of the time.
Reflux symptoms showed an interesting protective association with progression, with people reporting symptoms having only 36 percent of the odds of progression compared to those without symptoms. This likely reflects detection bias, where symptomatic patients receive more intensive monitoring. Dietary quality and physical activity, despite being measured carefully, did not independently predict outcomes. Alcohol use and BMI also showed no significant associations in the final models
Previous research has suggested that genetic factors might play a role in Barrett’s esophagus progression, but this large study provides strong evidence that lifestyle factors dominate. The finding that smoking is a major risk factor aligns with decades of cancer research showing smoking’s harmful effects. The lack of predictive value from polygenic risk scores contrasts with some other cancer types where genetic information has proven more useful, suggesting that Barrett’s esophagus progression is primarily driven by modifiable factors
The study had relatively few progression events (only 21 people), which limits confidence in the progression findings. The genetic analysis only included 739 of 870 participants. The study population may not represent all ethnic groups equally, which matters because genetic risk scores are often less accurate in non-European populations. The study measured lifestyle factors at baseline, so changes over the 10-year period were not captured. Finally, this was an observational study, so while it shows associations, it cannot prove that smoking causes progression
The Bottom Line
If you have Barrett’s esophagus, focus on quitting smoking and managing acid reflux symptoms through medication or lifestyle changes. These factors have strong evidence for reducing progression risk. Genetic testing for Barrett’s esophagus risk is not currently recommended based on this evidence. Regular endoscopic surveillance as recommended by your gastroenterologist remains the standard approach. Confidence level: High for smoking cessation; Moderate for reflux management
This research is most relevant for people with diagnosed Barrett’s esophagus, their doctors, and gastroenterologists making surveillance decisions. It’s also important for genetic testing companies and insurance companies deciding whether to cover polygenic risk testing for this condition. People with chronic acid reflux who haven’t been diagnosed with Barrett’s esophagus should know that smoking is a particular risk factor if they do develop it
The study followed people for up to 10 years, so benefits from smoking cessation would likely take months to years to become apparent. Most progression events occurred over several years rather than months, suggesting that lifestyle changes need to be sustained long-term to have meaningful impact
Frequently Asked Questions
Should I get genetic testing if I have Barrett’s esophagus?
Current evidence suggests genetic testing adds little value for Barrett’s esophagus risk prediction. Focus instead on modifiable factors like quitting smoking and managing acid reflux. Discuss surveillance options with your gastroenterologist rather than pursuing genetic testing
How much does smoking increase my risk of Barrett’s esophagus getting worse?
Smokers with Barrett’s esophagus have 4.31 times higher odds of disease progression compared to non-smokers. This makes smoking the single most important modifiable risk factor. Quitting smoking is the most effective step you can take to reduce progression risk
Can diet changes help prevent Barrett’s esophagus from progressing?
This large 10-year study found that dietary factors and diet quality did not independently predict disease progression. While healthy eating is generally beneficial, the evidence specifically supporting diet changes for Barrett’s esophagus progression is weak. Smoking cessation remains the priority
Does having reflux symptoms mean my Barrett’s esophagus will get worse?
Interestingly, people with reflux symptoms actually had lower progression rates, likely because symptoms prompt closer medical monitoring. However, this doesn’t mean reflux is beneficial. Treating reflux symptoms with medication or lifestyle changes remains important for comfort and overall health
What’s the most important thing I can do if I have Barrett’s esophagus?
Quit smoking if you smoke. Research shows this is the single most impactful action. Additionally, manage acid reflux symptoms through medication or lifestyle changes, and follow your doctor’s recommended surveillance schedule with regular endoscopy
Want to Apply This Research?
- Track daily smoking status and number of cigarettes if applicable, along with weekly reflux symptom frequency using a simple 0-10 scale. This creates a concrete record of the two most important modifiable risk factors
- Set a smoking cessation goal with a specific quit date. Use the app to log daily progress, track triggers, and record reflux symptoms before and after quitting to visualize the connection between smoking and symptoms
- Maintain a 12-month rolling view of smoking status and reflux frequency. Flag any return to smoking for immediate intervention. Share monthly summaries with your gastroenterologist to inform surveillance decisions
This research provides important information about Barrett’s esophagus risk factors but should not replace personalized medical advice. If you have been diagnosed with Barrett’s esophagus, work with your gastroenterologist to develop an individualized surveillance and treatment plan. Do not make decisions about genetic testing, smoking cessation medications, or reflux treatment without consulting your healthcare provider. This article summarizes research findings and does not constitute medical advice
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.